You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 16, 2025

Drug Price Trends for FT STOOL SOFTENER-STIM LAX TAB


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for FT STOOL SOFTENER-STIM LAX TAB

Average Pharmacy Cost for FT STOOL SOFTENER-STIM LAX TAB

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
FT STOOL SOFTENER-STIM LAX TAB 70677-1094-01 0.02860 EACH 2025-01-22
FT STOOL SOFTENER-STIM LAX TAB 70677-1094-01 0.02824 EACH 2024-12-18
FT STOOL SOFTENER-STIM LAX TAB 70677-1094-01 0.02864 EACH 2024-11-20
FT STOOL SOFTENER-STIM LAX TAB 70677-1094-01 0.02889 EACH 2024-10-23
FT STOOL SOFTENER-STIM LAX TAB 70677-1094-01 0.02568 EACH 2024-09-18
FT STOOL SOFTENER-STIM LAX TAB 70677-1094-01 0.02852 EACH 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for FT STOOL SOFTENER-STIM LAX TAB

Market Overview

The global laxatives market, which includes stool softeners and stimulant laxatives, is experiencing significant growth driven by several key factors. Here are some critical points to consider:

  • Growing Demand: The laxatives market was valued at USD 4999.21 million in 2017 and is expected to reach USD 7238.85 million by 2025, growing at a CAGR of 5.6%[3].
  • Segmentation: The market is segmented by type, including osmotic laxatives, stimulant laxatives, stool softener laxatives, and bulk forming laxatives. Stool softeners, in particular, are seeing robust growth due to their effectiveness and ease of use[1][4].

Stool Softener Market Dynamics

  • Growth Drivers: The stool softener market is driven by an increasing geriatric population suffering from constipation, rising adoption of sedentary lifestyles, and higher incidences of opioid-induced constipation. Additionally, the shift of many stool softeners from prescription-only to over-the-counter status has boosted market growth[4][5].
  • Regional Performance: North America is a significant market for stool softeners, driven by the high prevalence of constipation among older adults and the ease of access to treatments. The region is expected to continue its rapid revenue growth due to these factors[3][4].

Product Specifics: FT STOOL SOFTENER-STIM LAX TAB

  • Type and Form: FT STOOL SOFTENER-STIM LAX TAB combines the properties of both stool softeners and stimulant laxatives, making it a versatile product for treating constipation. It is available in tablet form, which is one of the most common and preferred forms of laxatives[1][5].

Price Trends

  • Current Pricing: The average pharmacy cost for similar stool softener-stimulant laxative tablets has been fluctuating but generally remains stable. For example, the price for GNP STOOL SOFTENER-STIM LAX TB has ranged from $0.02568 to $0.03165 per unit in recent months[2].
  • Price Projections: Given the overall market trends, it is likely that the prices of FT STOOL SOFTENER-STIM LAX TAB will remain competitive. The market is expected to see continued growth, but price increases are likely to be moderate due to competition and regulatory pressures.

Market Segmentation and Distribution

  • Distribution Channels: The product is distributed through various channels including hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. This wide distribution network ensures easy access for consumers, which is a key factor in market growth[1][3].
  • Geographical Distribution: The product is likely to perform well in regions with high prevalence of constipation, particularly North America and Europe, where there is a significant geriatric population and high healthcare spending[3][4].

Competitive Landscape

  • Key Players: The laxatives market is dominated by major pharmaceutical companies such as AstraZeneca plc, Boehringer Ingelheim GmbH, Bayer AG, GlaxoSmithKline, and Abbott Laboratories. These companies are continually innovating and expanding their product lines to capture market share[1].
  • Market Strategies: Companies are deploying various strategies including mergers and acquisitions, strategic agreements, and the development of more effective formulations to stay competitive. The introduction of new and innovative products, such as effervescent stool softener tablets, is also a trend in the market[4][5].

Future Outlook

  • Growth Projections: The stool softener market is expected to grow from $1.58 billion in 2023 to $2.26 billion by 2028 at a CAGR of 7.5%. This growth is driven by increasing cases of gastrointestinal conditions, higher healthcare spending, and the development of more effective formulations[5].
  • Technological Innovations: Improvements in medical diagnostics and treatments, along with innovations in formulation technology, are expected to drive the market forward. Personalized stool softener products and new delivery methods are also anticipated to contribute to market growth[5].

Key Takeaways

  • The global laxatives market, including stool softeners and stimulant laxatives, is growing steadily.
  • FT STOOL SOFTENER-STIM LAX TAB benefits from being a combinatory product that addresses multiple needs.
  • Price trends are expected to remain stable with moderate increases due to market competition.
  • Distribution through various channels ensures wide accessibility.
  • The market is driven by an aging population, sedentary lifestyles, and opioid-induced constipation.
  • Technological innovations and personalized products are expected to drive future growth.

FAQs

Q: What is the current market size of the global laxatives market? A: The global laxatives market was valued at USD 4999.21 million in 2017 and is expected to reach USD 7238.85 million by 2025[3].

Q: What are the key drivers of the stool softener market? A: The key drivers include an increasing geriatric population, rising adoption of sedentary lifestyles, and higher incidences of opioid-induced constipation[4].

Q: Which region is the largest market for laxatives? A: North America, particularly the US and Canada, is the largest regional market for laxatives due to the high prevalence of constipation and ease of access to treatments[3].

Q: What is the expected CAGR of the stool softener market from 2023 to 2028? A: The stool softener market is expected to grow at a CAGR of 7.5% from 2023 to 2028[5].

Q: What are some of the technological innovations expected in the laxatives market? A: Innovations include improvements in medical diagnostics, new formulation technologies, personalized stool softener products, and the development of effervescent stool softener tablets[5].

Sources

  1. Research and Markets, "Global $8.71 Billion Laxatives Market Analysis & Trends to 2025"[1]
  2. Drug Patent Watch, "Drug prices and trends for GNP STOOL SOFTENER-STIM LAX TB"[2]
  3. Research and Markets, "Global Laxatives Market to 2025 - Research and Markets"[3]
  4. Emergen Research, "Stool Softener Industry Trend, Forecast [2021-2030] | Market Report"[4]
  5. The Business Research Company, "Stool Softener Global Market Report 2024"[5]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.